Rational Elimination of Side Reactions and/or Tolerance in the Development of Potentially Valuable Drugs
- 1 February 1952
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 3 (1) , 36-41
- https://doi.org/10.1177/000331975200300105
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The Activities of 1-Hydrazinophthalazine (Ba-5968), a Hypotensive Agent*Journal of the American Pharmaceutical Association (Scientific ed.), 1951
- Suppression of Vasomotor Reflexes in Man Following L-Hydrazinophthalozine (C-5968).Experimental Biology and Medicine, 1950
- Zur Pharmakologie des N,N,N′,N′-3-Pentamethyl-N,N′-diäthyl-3-aza-pentan-1,5-diammonium-dibromid (Ciba 9295), einer ganglionär hemmenden SubstanzCellular and Molecular Life Sciences, 1950
- Eine neue Gruppe blutdrucksenkender Substanzen von besonderem WirkungscharakterCellular and Molecular Life Sciences, 1950
- THE EFFECTS OF PRISCOL (2-BENZYL-4, 5-IMIDAZOLINE HC1) ON PERIPHERAL VASCULAR DISEASES, HYPERTENSION AND CIRCULATION IN PATIENTSAnnals of Surgery, 1948
- THE USE OF HISTAMINE IN THE TREATMENT OF SPECIFIC TYPES OF HEADACHESJAMA, 1941
- MECHANISM OF MIGRAINE HEADACHE AND ACTION OF ERGOTAMINE TARTRATEArchives of Neurology & Psychiatry, 1938